Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

D.G.M. Murphy

21 indexed publications match this author name.

ORCID: 0000-0002-6664-7451
OpenAlex: https://openalex.org/A5121832208

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Depression 10 Clinical Trial 7 Receptor Pharmacology 7 Brain Imaging 6 Emotional Processing 4 Safety 4 Mechanism of Action 4 Personality Change 4 Adverse Events 3 Aging 3 Anxiety 3 PTSD 3

Journals

Neuroscience Applied 4 medRxiv 2 Psychological medicine 2 Pharmacology 1 BMJ supportive & palliative care 1 EClinicalMedicine 1 BMC psychiatry 1 Neuroethics 1

Publication history

Distinct response of resting-state brain networks to psilocybin in autismmedRxiv · 2026-08-22 An Open-Label Trial Protocol to Test Menstrual Cycle Effects and Tolerance to Low-Dose Psilocybin in Healthy Menstruating Persons.Pharmacology · 2026-08-10 Psilocybin-assisted therapy for demoralisation in hospice patients: feasibility, safety and preliminary efficacy.BMJ supportive & palliative care · 2026-02-27 Dynamic response of intrinsic connectivity networks to low-dose psilocybin during face matching in autistic adultsNeuroscience Applied · 2026-01-01 Low dose psilocybin differentially alters resting-state network connectivity in autistic and non-autistic peopleNeuroscience Applied · 2026-01-01 Effects of low-dose psilocybin on EEG markers of sensory processing in autistic and non-autistic adultsNeuroscience Applied · 2026-01-01 Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial.EClinicalMedicine · 2024-10-01 The 'PSILAUT' protocol: an experimental medicine study of autistic differences in the function of brain serotonin targets of psilocybin.BMC psychiatry · 2024-04-25 Psilocybin vs Escitalopram for depression: 6-month follow-upNeuroscience Applied · 2024-01-01 Personality change in a trial of psilocybin therapy v. escitalopram treatment for depression.Psychological medicine · 2024-01-01 Personality Change in a Trial of Psilocybin Therapy vs Escitalopram Treatment for Depression - CORRIGENDUM.Psychological medicine · 2024-01-01 When the Trial Ends: The Case for Post-Trial Provisions in Clinical Psychedelic Research.Neuroethics · 2024-01-01 Theorizing that Psychedelic Assisted Therapy May Play a Role in the Treatment of Trauma-Induced Personality Disorders.Journal of addiction psychiatry · 2024-01-01 Beliefs and Perceived Barriers Regarding Psychedelic-assisted Therapy in a Pilot Study of Service Members and Veterans With a History of Traumatic Brain Injury.Military medicine · 2023-11-03 Psilocybin-assisted psychotherapy for the treatment of PTSD in UK armed forces veterans: A feasibility study protocolEuropean Journal of Trauma & Dissociation · 2023-10-25 Extended difficulties following the use of psychedelic drugs: A mixed methods studyPLoS ONE · 2023-10-23 Bridging the translational neuroscience gap: Development of the ‘shiftability’ paradigm and an exemplar protocol to capture psilocybin-elicited ‘shift’ in neurobiological mechanisms in autismmedRxiv · 2023-05-26 Trial of Psilocybin versus Escitalopram for Depression.The New England journal of medicine · 2021-04-15 Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression.Frontiers in pharmacology · 2021-01-01 Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms.Scientific reports · 2017-10-13 Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin.Proceedings of the National Academy of Sciences of the United States of America · 2012-02-07

Author directory